DaVita
DVA
#1829
Rank
A$16.34 B
Marketcap
A$254.72
Share price
0.82%
Change (1 day)
26.49%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): A$18.34

According to DaVita's latest financial reports the company's current EPS (TTM) is A$18.03. In 2025 the company made an earnings per share (EPS) of A$14.62 a decrease over its 2024 EPS that were of A$15.93.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$18.3425.49%
2025A$14.62-8.25%
2024A$15.9344.94%
2023A$10.9927.26%
2022A$8.64-35.56%
2021A$13.4044.1%
2020A$9.3019.7%
2019A$7.77540.48%
2018A$1.21-76.07%
2017A$5.07-19.31%
2016A$6.28242.52%
2015A$1.83-62.87%
2014A$4.9413.43%
2013A$4.358.45%
2012A$4.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
A$35.86 98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$17.58-2.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
A$37.73 109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$3.06-83.04%๐Ÿ‡บ๐Ÿ‡ธ USA